Skip to main content

Table 4 Comparison of clinicopathological parameters of 97 locally advanced esophageal squamous cell carcinoma patients who received curative concurrent chemoradiotherapy according to VEGF day 28 level

From: The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy

Characteristics

VEGF < 80 pg/mL group (N = 29)

VEGF > 80 pg/mL group (N = 68)

P value

Age

  < 60 years

21 (72%)

43 (63%)

0.38

  ≥ 60 years

8 (28%)

25 (37%)

 

T status

 1 + 2

8 (28%)

7 (10%)

0.031a

 3 + 4

21 (72%)

61 (90%)

 

N status

 0 + 1

9 (31%)

22 (32%)

0.90

 2 + 3

20 (69%)

46 (68%)

 

Stage

 II + IIIA + IIIB

11 (38%)

21 (31%)

0.50

 IIIC

18 (62%)

47 (69%)

 

Grade

 1 + 2

22 (76%)

49 (72%)

0.70

 3

7 (24%)

19 (28%)

 

Location

 Upper

14 (48%)

26 (38%)

0.36

 Middle + Lower

15 (52%)

42 (62%)

 
  1. VEGF vascular endothelial growth factor
  2. aStatistically significant